Luxmed Onkologia sp. z o. o.

Warsaw 01-748

2 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Breast Neoplasms, CRC (Colorectal Cancer), Carcinoma, Transitional Cell, Colorectal Cancer, Cutaneous Melanoma, Locally Advanced or Unresectable Metastatic Breast Cancer, Neoplasm Metastasis, Prostate Cancer Metastatic, Solid Tumor, Adult, Squamous Cell Non Small Cell Lung Cancer, Stage IV Breast Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• MGD019 DART® Protein in Unresectable/Metastatic Cancer — Completed